Table 3. The diagnostic performance of four markers and ANN models for all stages HCC and early stage HCC cases in cirrhotic patients.
Markers | HCC vs LC | Early HCC vs LC | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
AUC | p Value | Cut-off | Sensitivity | Specificity | AUC | p Value | Cut-off | Sensitivity | Specificity | |
AFP(ng/mL) | 0.713(0.659-0.767) | <0.001 | 49.4 | 0.564 | 0.822 | 0.650(0.575-0.725) | <0.001 | 43.7 | 0.469 | 0.809 |
GP73(ng/mL) | 0.618(0.559-0.677) | <0.001 | 148.6 | 0.921 | 0.344 | 0.703(0.630-0.776) | <0.001 | 181.4 | 0.770 | 0.593 |
AFP-L3(ng/mL) | 0.730(0.678-0.782) | <0.001 | 8.028 | 0.523 | 0.895 | 0.672(0.597-0.748) | <0.001 | 3.813 | 0.494 | 0.842 |
DCP(mAU/mL) | 0.764(0.714-0.814) | <0.001 | 28.1 | 0.621 | 0.855 | 0.609(0.527-0.690) | 0.006 | 13.7 | 0.605 | 0.645 |
MLP-Models | 0.753(0.701-0.806) | <0.001 | 0.5 | 0.697 | 0.809 | 0.692(0.616-0.768) | <0.001 | 0.5 | 0.469 | 0.914 |
RBF-Models | 0.742(0.688-0.795) | <0.001 | 0.5 | 0.733 | 0.750 | 0.659(0.582-0.735) | <0.001 | 0.5 | 0.481 | 0.836 |